Skip to main content

Home/ Health affairs/ Group items tagged DISORDERS

Rss Feed Group items tagged

pharmacybiz

Bipolar Disorder : Symptoms and Treatments - 0 views

  •  
    Bipolar disorder can be a very challenging mental illness to deal with. It is characterized by severe mood swings, from manic highs to depressive lows. Many people with bipolar disorder struggle to live normal, productive lives. However, there are various treatments available that can help manage the symptoms of this condition and improve quality of life. In this article, we will discuss the different treatments for bipolar disorder and how to properly deal with the symptoms. MEDICATIONS One of the most common treatments for bipolar disorder is medication. There are a variety of different medications that can be used to treat the symptoms of bipolar disorder. The type of medication that is prescribed will depend on the individual's specific situation. Some common medications that are used to treat bipolar disorder include mood stabilizers, antipsychotics, and antidepressants. However, it is important to note that these are serious medications and should only be taken under the supervision of a qualified mental health professional. So, never attempt to take these medications on your own.
pharmacybiz

Autism Spectrum Disorder: How To Deal With it - 0 views

  •  
    An autism spectrum disorder is a neurological and developmental disorder that affects a person's ability to communicate, interact with others, and process information. There is no one-size-fits-all for people with ASD, as each experiences symptoms differently. While some people with ASD may be nonverbal, others may speak fluently but have difficulty with social interaction. Most people with ASD need specialized educational and behavioral intervention early. There is no medical cure for ASD, but treatments and therapies can improve symptoms and help people with ASD lead fulfilling lives. If you or your child has just been diagnosed with autism spectrum disorder (ASD), it's normal to feel a range of emotions. You may feel relieved to finally have a diagnosis and explanation for your or your child's symptoms. Or you may feel overwhelmed, worried, or even angry about the diagnosis.
pharmacybiz

Anxiety: How you can support your family member? - 0 views

  •  
    If your loved one is suffering from anxiety, you'll likely be aware of how damaging the condition can be. Anxiety comes in many forms and can be triggered by an array of factors, but there are some simple steps to take if you want to improve the wellbeing of your family member - how can you best go about supporting a loved one with anxiety? What is anxiety? - Anxiety is mental state in which we feel highly worried, nervous, uneasy, or uncomfortable. While it's normal to feel anxious in certain situations and at notable points in our lives (this is linked to the 'fight or flight' instinct), it's important to address the problem if you feel that your anxiety is impacting your quality of life. What are the five major forms of anxiety? - The 5 most common forms of anxiety as diagnosed by medical professionals include generalised anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder and social phobia, also known as anxiety disorder. What causes anxiety problems? - Anxiety can be caused by a wide range of factors. We're more likely to become anxious when we're overworked, stressed, depressed, under financial pressure or physically or mentally unwell. It's also common to become anxious after traumatic events such as having to make medical negligence claim after sustaining a surgical based injury, losing a home or the death of a loved one.
pharmacybiz

NHS Introduces World-First Genetic Test for Sickle Cell and Thalassaemia - 0 views

  •  
    The UK's National Health Service (NHS) has become the first healthcare system in the world to provide a new blood group genotyping test for people with rare inherited blood disorders. From Monday (22 January), thousands of patients suffering from sickle cell disorder and thalassaemia will get access to the world-first 'blood matching' genetic test, which will help reduce their risk of transfusion side effects while offering more personalised care. In England, it is estimated that around 17,000 people are living with sickle cell disorder, with 250 new cases reported each year, and there are about 800 thalassaemia patients, with less than 50 new cases a year. Health Minister Andrea Leadsom said: "Thousands of people living with sickle cell disease and thalassaemia will be eligible for this new world-first blood test which is set to transform their care.
pharmacybiz

Stay Informed: Aripiprazole Side Effects & Gambling Risks - 0 views

  •  
    The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals prescribing aripiprazole to alert patients about its possible side effects, following a rise in the number of reports of gambling disorder associated with the drug. Patients taking aripiprazole, which is used for the treatment of schizophrenia and bipolar disorder, are at risk of developing unusual urges or cravings that they cannot resist, including behaviours such as addictive gambling, excessive eating or spending, or an abnormally high sex drive. The regulator has received 69 reports of gambling or gambling disorder suspected to be caused by aripiprazole in the last 14 years via the Yellow Card Scheme, out of which 32 were received between 1 January and 31 August this year. Alison Cave, MHRA Chief Safety Officer, said: "The number of reports for suspected gambling and other impulsive behaviours associated with aripiprazole are small in comparison to the frequency with which it is prescribed, but the consequences for any patient developing these conditions can be significant."
pharmacybiz

Valproate Alert: Men's Fertility Risks Revealed - MHRA Caution - 0 views

  •  
    The Medicine and Healthcare products Regulatory Agency (MHRA) has cautioned men on valproate to talk to their healthcare professional about their treatment, if they want to start a family in the next year. The warning came after a new study, commissioned by the European Medicines Agency, suggested that children fathered by men who took the anti-seizure medicine in the three months prior to conception may be at higher risk of developing neurodevelopmental disorders. Around five in 100 children born to fathers treated with valproate around conception were diagnosed with a neurodevelopmental disorder, compared to three in 100 children whose fathers were taking other antiseizure medicines (lamotrigine or levetiracetam). However, the risk is believed to be much smaller than the risk associated with valproate in pregnancy.
pharmacybiz

Study indicates baby teeth may lead to spotting mental disorders in children - Latest P... - 0 views

  •  
    Baby teeth could one day lead to the development of a much-needed tool for identifying children who are at risk for psychological problems, a study by the University of Bristol has concluded. The research has been published in the 'JAMA Network Open' - a monthly journal published by the American Medical Association. The origin of this study traces back several years, when senior author Erin Dunn - a social and psychiatric epidemiologist and an investigator in MGH's Psychiatric and Neurodevelopmental Genetics Unit - learned about work in the field of anthropology that could help solve a longstanding problem in her own research. She studies the effects of childhood adversity, which research suggested, is responsible for up to one-third of all mental health disorders. Dunn is particularly interested in the timing of these adverse events and in uncovering whether there are sensitive periods during child development when exposure to adversity is particularly harmful.
pharmacybiz

Gene therapy to treat rare bleeding disorder - 0 views

  •  
    The European Union's health regulator on Friday said it had recommended granting a conditional marketing authorisation for a gene therapy by Australian drugmaker CSL Ltd and partner uniQure N.V. , to treat haemophilia B, a rare bleeding disorder which is caused by genetic anomalies. About one in 40,000 people are affected by the inherited disorder, caused by a gene mutation that hampers the body's ability to make clotting protein factor IX. If approved, the treatment, branded Hemgenix, will be the first gene therapy in the European Union for the condition that is usually treated by regular injections of factor IX, the European Medicines Agency said. CSL had acquired exclusive global rights to Hemgenix in May last year from uniQure N.V.
healthpost07

How to know Symptoms of Genetic disorder? - 0 views

  •  
    Audio link How to know Symptoms of Genetic disorder? ? What are the side effects and Treatment?
  •  
    Audio link How to know Symptoms of Genetic disorder? ? What are the side effects and Treatment?
healthpost07

How to know Symptoms of Skin Disorders? - 0 views

  •  
    Audio link How to know Symptoms of Skin Disorders? What are the side effects and Treatment?
  •  
    Audio link How to know Symptoms of Skin Disorders? What are the side effects and Treatment?
fnfdoc

Acne Problems Diagnose And Treatment | Your Health Our Priority - 0 views

  •  
    Acne commonly named vulgaris, a disorder of hair follicles of the face, back and chest or neck.acne also characterized by blackheads or whiteheads on oily skin (Pimples). Dermatologists find different treatments for improvement of this disorder by regulating oil-producing glands.
rambo007

Top 10 Holy Basil Leaf Health Benefits And Side Effects You Never Knew - 0 views

  •  
    Holy basil is known as the queen of herbs, it especially works in the treatment of oral care, respiratory disorder, asthma, lung disorders. The scientific name of this sacred basil is osmium sanctum. Ayurveda has been described in terms of its infinite miraculous use. Here is a little information about the holy basil. Let's know holy basil leaf health benefits.
pharmacybiz

Schizophrenia and depression caused by smoking - 0 views

  •  
    Smoking increases the risk of developing schizophrenia and depression, a report by academics from the University of Bristol published on 20 June claims. It says smoking raises the risk of developing schizophrenia by between 53 per cent and 127 per cent and the risk of developing depression by from 54 per cent to 132 per cent. The authors of the report say more research is needed to identify why this is the case and that more evidence is needed to understand its impact on other mental health conditions such as anxiety or bipolar disorder. The evidence, presented at the Royal College of Psychiatrist's international congress, has been shared with the government which is currently developing a new Tobacco Control Plan for publication later this year. Action on Smoking and Health (ASH) said: "Rates of smoking are much higher among people with mental health conditions than those without, and among England's six million smokers there are an estimated 230k smokers with severe mental illness (e.g., schizophrenia and bi-polar disorder) and 1.6 million with depression and anxiety."
healthpost07

How to know Symptoms of Rheumatic Disorder - 0 views

  •  
    Audio How to know Symptoms of Rheumatic Disorder
pharmacybiz

Shocking Mental Health Stats: Alarming Youth Crisis - 0 views

  •  
    A new report, published by the Office of National Statistics (ONS), has revealed worrying statistics about the mental health of children and young people in England. The report is based on NHS survey on Mental Health of Children and Young People in England 2023, which showed that one in five children and young individuals aged eight to 25 were grappling with probable mental disorders. The report highlighted that 20.3 per cent of eight to 16-year-olds showed signs of mental distress in 2023. Among 17 to 19-year-olds, the proportion rose to 23.3 per cent, while in 20 to 25-year-olds, it stood at 21.7 per cent. The rates of probable mental disorders were similar for boys and girls, while for 17- to 25-year-olds, rates were twice as high for young women than young men.
pharmacybiz

Urgent : Guanfacine Tablets Unavailable Until May 6, 2024 - 0 views

  •  
    The Department of Health and Social Care (DHSC) published a notification regarding the shortage of Guanfacine 2mg and 3mg modified-release tablets has raised concerns within the healthcare community. This critical medicine supply notification, issued on March 28th, projects the unavailability of these tablets until the week commencing May 6, 2024. Guanfacine tablets, commonly prescribed to alleviate symptoms of hyperactivity and impulsivity while enhancing attention and concentration, play a vital role in managing conditions like attention deficit hyperactivity disorder (ADHD). However, the scarcity of these specific strengths poses challenges for patients reliant on this medication. Last year, several countries across the globe experienced shortages of medications for the treatment of attention deficit hyperactivity disorder (ADHD)including the UK, the US and Australia. Community Pharmacy England (CPE) has cautioned that while alternative strengths of Guanfacine remain accessible, they may not adequately meet the heightened demand, potentially resulting in treatment interruptions for patients.
healthpost07

How to know Post traumatic stress disorder? - 0 views

  •  
    Audio link How to know Post traumatic stress disorder? What are its main signs and symptoms?
healthpost07

How to know Symptoms of Penis Disorders? - 0 views

  •  
    Audio link How to know Symptoms of Penis Disorders? What are the main effects and symptoms of the disease?
healthpost07

How to know about Panic Attacks Disorder? - 0 views

  •  
    Audio link How to know about Panic Attacks Disorder? What are the main effects and symptoms of the disease?
kailashdh

Unmasking Thyroid Disorders: Identifying Warning Signs in Men - 0 views

  •  
    Uncover the warning signs of thyroid disorders in men and provide insights from Dr. Ashish Saini, Consultant Endocrinologist at Kailash Deepak Hospital.
1 - 20 of 69 Next › Last »
Showing 20 items per page